Summary
McKesson Corporation (MCK) disclosed in an 8-K filing dated April 8, 2005, that it has received a subpoena from the Office of the Attorney General of the State of New York. The subpoena requests documents and information pertaining to the secondary wholesale market for pharmaceutical products. The company has indicated its full intention to cooperate and respond to the subpoena. This disclosure is important for investors as it signals a potential regulatory inquiry into the company's operations within the pharmaceutical distribution sector. While the filing does not provide details on the nature of the investigation, it highlights a developing legal and regulatory issue that could have implications for McKesson's business practices and market position.
Key Highlights
- 1McKesson Corporation received a subpoena from the New York Attorney General's Office.
- 2The subpoena requests information related to the secondary wholesale market for pharmaceutical products.
- 3The company has stated its intention to fully cooperate with the Attorney General's request.
- 4This filing falls under Regulation FD disclosure.
- 5The event date reported is April 7, 2005, with the filing date of April 8, 2005.